Group 1: Stock Performance and Price Targets - Abacus Life, Inc. (ABL) shares have increased by 3.7% over the past four weeks, closing at $10.30, with a mean price target of $13.67 indicating a potential upside of 32.7% [1] - The average price target consists of three estimates ranging from $12 to $15, with a standard deviation of $1.53, suggesting a relatively high agreement among analysts [1][4] - The lowest estimate suggests a 16.5% increase, while the highest points to a 45.6% upside [1] Group 2: Analyst Sentiment and Earnings Estimates - Analysts show strong agreement regarding ABL's ability to report better earnings than previously predicted, which supports the potential for stock upside [2][5] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.6%, with no negative revisions, indicating positive sentiment [5] - ABL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [5] Group 3: Price Target Limitations - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [2][3] - Empirical research indicates that price targets often mislead investors rather than guide them, with analysts sometimes setting overly optimistic targets due to business incentives [3] - A low standard deviation in price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [4]

New partnership leverages PREADISAN™, the cutting-edge health prediction platform using machine learning and modern proteomicsApplies novel big data analytics tools to the Abacus portfolio of servicesLorisco's risk scores will enable a more personalized approach to longevity and actuarial technology to maximize value for Abacus’ clients ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity an ...

Financial Data and Key Metrics Changes - Total revenue for Q2 2024 more than doubled year-over-year to $29.1 million from $11.4 million [16] - Adjusted EBITDA grew 83% year-over-year to $16.7 million, with an adjusted EBITDA margin of 57.5% compared to 80.4% in the prior year [18] - Adjusted net income increased 75% year-over-year to $11.8 million or $0.18 per diluted share [8][18] - Total operating expenses for Q2 2024 were approximately $18.9 million, significantly higher than $1.3 million in the prior year period, influenced by non-cash stock compensation and public company expenses [17] Business Line Data and Key Metrics Changes - Origination capital deployed was $104.7 million, up from $59.8 million in the prior year [15] - Policies purchased increased by 95% to 275 compared to 141 in the prior year period [15] - The company held 458 policies as of June 30, 2024, with 452 accounted for under the fair value method [16] Market Data and Key Metrics Changes - The company established a national distribution relationship with Amcor, enhancing its ability to offer protection and retirement solutions [12] - The acquisition of Carlisle Management Company will add approximately $2 billion in assets under management, while FCF Advisors will add about $600 million [9][11] Company Strategy and Development Direction - The company aims to solidify its position as a leading market maker and global alternative asset manager, targeting nearly $3 billion in assets under management post-acquisitions [7] - Focus on expanding complementary lifespan-based financial products alongside the core business of acquiring life insurance policies [8] - The company is committed to constant innovation through its wealth of longevity and actuarial data [13] Management's Comments on Operating Environment and Future Outlook - Management expressed excitement about the growth opportunities ahead, leveraging their successful business model and proprietary data [13] - The company anticipates deploying the majority of the raised capital before year-end, potentially as early as Q3 [24] - Management remains optimistic about maintaining strong performance in the second half of the year, despite managing expectations [26] Other Important Information - The company successfully closed an oversubscribed public offering of 11.5 million shares, raising over $90 million [11] - Total originated face value for the quarter was $447 million, with opportunities to acquire policies from other asset managers [31] Q&A Session Summary Question: Can you discuss deployment and capacity for the raised capital? - Management expects to deploy the majority of the raised capital before year-end, potentially as early as Q3, capitalizing on increased policy flow [24] Question: What are the expectations for adjusted EBITDA for the full year? - Management indicated that while Q2 was strong, they want to manage expectations for Q3 and Q4, but overall numbers look positive [26] Question: What was the originated face value in the quarter? - The total originated face value for the quarter was $447 million, with opportunities to acquire policies outside of their origination platform contributing to the high volume [31] Question: How do you see active management revenue trending? - Management believes the active management revenue is sustainable and profitable, with a strong return on equity [32] Question: What is the outlook for M&A activity? - Management will continue to be opportunistic with M&A, focusing on integrating acquired companies successfully [38] Question: What progress has been made on the Abacus Tech front? - ABL Tech continues to grow, adding new clients and providing recurring fee earnings [41] Question: What are the current market opportunities? - Management sees significant market opportunities, with pent-up demand and a broader set of policies available for purchase at better rates [47]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 ...

- Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Grows 83% Year-over-Year to $16.7 Million - ORLANDO, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the second quarter ended June 30, 2024. ...

Company Overview - Abacus Life, Inc. (ABL) shares increased by 20.3% to close at $10.08, following a notable trading volume, contrasting with a 14.1% loss over the past four weeks [1] - The company expects second quarter revenues between $28 million and $30 million, significantly higher than the previous year's $11 million [1] - Abacus anticipates adjusted EBITDA of $15 million to $17 million and net income between $0 million and $1 million [1] Recent Developments - Abacus Life has agreed to acquire Carlisle Management Company, which will add $2 billion in assets under management, enhancing its position as a global alternative asset manager [2] - The company is shifting towards direct-to-consumer distribution, moving away from higher-cost intermediaries, which is expected to support growth [2] - Abacus operates in a market with substantial growth potential and has opportunities for increased market penetration [2] Earnings Expectations - The consensus EPS estimate for Abacus Life for the upcoming quarter is $0.12, reflecting a year-over-year decline of 7.7% [2] - Revenue expectations for the upcoming report are $22.82 million, representing a 100.5% increase from the same quarter last year [2] Market Trends - Trends in earnings estimate revisions are correlated with stock price movements, and the consensus EPS estimate for Abacus has remained unchanged over the last 30 days [3] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [3] Industry Context - Abacus Life is part of the Zacks Insurance - Life Insurance industry, which includes other companies like Brighthouse Financial (BHF) [3] - BHF's consensus EPS estimate has increased by 0.3% to $4.36, showing a year-over-year change of 5.6% [4]

- Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17.0 Million; Grows 64-86% Year-over-Year - - Schedules Second Quarter 2024 Earnings Release and Conference Call for Monday, August 12, 2024 - ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and act ...

Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA ("Carlisle"), a leading Luxe ...

Core Viewpoint - Abacus Life, Inc. has successfully closed an oversubscribed public offering, raising approximately $92 million through the sale of 11,500,000 shares at a price of $8.00 per share, which includes the full exercise of an option for an additional 1,500,000 shares [1]. Group 1: Offering Details - The public offering was underwritten and managed by Piper Sandler & Co., TD Securities (USA) LLC, B. Riley Securities, and KKR Capital Markets LLC [2]. - The registration statement for the offering was declared effective by the SEC on June 20, 2024, with a final prospectus filed on June 21, 2024 [3]. Group 2: Use of Proceeds - Abacus intends to utilize the net proceeds from the offering for operations, including the purchase of life settlement policies, working capital, and general corporate purposes, which may involve repayment and refinancing of its debt [1]. Group 3: Company Overview - Abacus is a leading alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of life insurance policies purchased since 2004 [5]. - The company operates through three innovative channels: ABL Tech, ABL Wealth, and ABL Longevity Funds, aiming to democratize the life insurance market [5].

Core Viewpoint - Abacus Life, Inc. has successfully closed an oversubscribed public offering, raising approximately $92 million through the sale of 11,500,000 shares at a price of $8.00 per share, which includes the full exercise of an option for an additional 1,500,000 shares [1]. Group 1: Offering Details - The public offering was underwritten and managed by Piper Sandler & Co., TD Securities (USA) LLC, B. Riley Securities, and KKR Capital Markets LLC [2]. - The registration statement for the offering was declared effective by the SEC on June 20, 2024, with a final prospectus filed on June 21, 2024 [3]. Group 2: Use of Proceeds - Abacus intends to utilize the net proceeds from the offering for operations, including the purchase of life settlement policies, working capital, and general corporate purposes, which may involve repayment and refinancing of its debt [1]. Group 3: Company Overview - Abacus is a leading alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of life insurance policies purchased since 2004 [5]. - The company operates through three innovative channels: ABL Tech, ABL Wealth, and ABL Longevity Funds, aiming to democratize the life insurance market [5].